Market Executive Summary
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The global CAR T-Cell Therapy market size is expected to reach US$ 13510 million by 2029, growing at a CAGR of 29.9% from 2023 to 2029. The market is mainly driven by the significant applications of CAR T-Cell Therapy in various end use industries. The expanding demands from the Lymphoma and Multiple Myeloma, are propelling CAR T-Cell Therapy market. CD19 - Targeted, one of the segments analysed in this report, is projected to record ?GR and reach US$ million by the end of the analysis period. Growth in the BCMA - Targeted segment is estimated at ?GR for the next seven-year period.
The global top three CAR T-Cell therapy players include Novartis, Gilead Sciences, Bristol-Myers Squibb, with a total market share of more than 99%. The largest player is Gilead Sciences, with a market share of over 50%. North America is the global most important consumer market for CAR T-Cell therapy, with a market share of more than 65%. In terms of type, CD19-targeted CAR cell therapy has a market share of over 90%. In the field of application, the market share of lymphoma exceeds 90%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for CAR T-Cell Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global CAR T-Cell Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global CAR T-Cell Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, CAR T-Cell Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of CAR T-Cell Therapy covered in this report include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline) and Sorrento Therapeutics(Pipeline), etc.
The global CAR T-Cell Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Global CAR T-Cell Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global CAR T-Cell Therapy market, Segment by Type:
CD19 - Targeted
BCMA - Targeted
Global CAR T-Cell Therapy market, by Application
Lymphoma
Multiple Myeloma
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of CAR T-Cell Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Table of Contents
1 Market Overview of CAR T-Cell Therapy
1.1 CAR T-Cell Therapy Market Overview
1.1.1 CAR T-Cell Therapy Product Scope
1.1.2 CAR T-Cell Therapy Market Status and Outlook
1.2 Global CAR T-Cell Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global CAR T-Cell Therapy Market Size by Region (2018-2029)
1.4 Global CAR T-Cell Therapy Historic Market Size by Region (2018-2023)
1.5 Global CAR T-Cell Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, CAR T-Cell Therapy Market Size (2018-2029)
1.6.1 North America CAR T-Cell Therapy Market Size (2018-2029)
1.6.2 Europe CAR T-Cell Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific CAR T-Cell Therapy Market Size (2018-2029)
1.6.4 Latin America CAR T-Cell Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa CAR T-Cell Therapy Market Size (2018-2029)
2 CAR T-Cell Therapy Market by Type
2.1 Introduction
2.1.1 CD19 - Targeted
2.1.2 BCMA - Targeted
2.2 Global CAR T-Cell Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global CAR T-Cell Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global CAR T-Cell Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America CAR T-Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe CAR T-Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific CAR T-Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America CAR T-Cell Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa CAR T-Cell Therapy Revenue Breakdown by Type (2018-2029)
3 CAR T-Cell Therapy Market Overview by Application
3.1 Introduction
3.1.1 Lymphoma
3.1.2 Multiple Myeloma
3.2 Global CAR T-Cell Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global CAR T-Cell Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global CAR T-Cell Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America CAR T-Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe CAR T-Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific CAR T-Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America CAR T-Cell Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa CAR T-Cell Therapy Revenue Breakdown by Application (2018-2029)
4 CAR T-Cell Therapy Competition Analysis by Players
4.1 Global CAR T-Cell Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2022)
4.3 Date of Key Players Enter into CAR T-Cell Therapy Market
4.4 Global Top Players CAR T-Cell Therapy Headquarters and Area Served
4.5 Key Players CAR T-Cell Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 CAR T-Cell Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis CAR T-Cell Therapy Products, Services and Solutions
5.1.4 Novartis CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Gilead Sciences
5.2.1 Gilead Sciences Profile
5.2.2 Gilead Sciences Main Business
5.2.3 Gilead Sciences CAR T-Cell Therapy Products, Services and Solutions
5.2.4 Gilead Sciences CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Gilead Sciences Recent Developments
5.3 Bristol-Myers Squibb
5.3.1 Bristol-Myers Squibb Profile
5.3.2 Bristol-Myers Squibb Main Business
5.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Products, Services and Solutions
5.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 J & J Recent Developments
5.4 J & J
5.4.1 J & J Profile
5.4.2 J & J Main Business
5.4.3 J & J CAR T-Cell Therapy Products, Services and Solutions
5.4.4 J & J CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 J & J Recent Developments
5.5 JW Therapeutics
5.5.1 JW Therapeutics Profile
5.5.2 JW Therapeutics Main Business
5.5.3 JW Therapeutics CAR T-Cell Therapy Products, Services and Solutions
5.5.4 JW Therapeutics CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 JW Therapeutics Recent Developments
5.6 FOSUNKite
5.6.1 FOSUNKite Profile
5.6.2 FOSUNKite Main Business
5.6.3 FOSUNKite CAR T-Cell Therapy Products, Services and Solutions
5.6.4 FOSUNKite CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 FOSUNKite Recent Developments
5.7 CARsgen Therapeutics (Pipeline)
5.7.1 CARsgen Therapeutics (Pipeline) Profile
5.7.2 CARsgen Therapeutics (Pipeline) Main Business
5.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Products, Services and Solutions
5.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
5.8 Autolus Therapeutics(Pipeline)
5.8.1 Autolus Therapeutics(Pipeline) Profile
5.8.2 Autolus Therapeutics(Pipeline) Main Business
5.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
5.8.4 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Autolus Therapeutics(Pipeline) Recent Developments
5.9 Sorrento Therapeutics(Pipeline)
5.9.1 Sorrento Therapeutics(Pipeline) Profile
5.9.2 Sorrento Therapeutics(Pipeline) Main Business
5.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
5.9.4 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Sorrento Therapeutics(Pipeline) Recent Developments
5.10 Mustang Bio(Pipeline)
5.10.1 Mustang Bio(Pipeline) Profile
5.10.2 Mustang Bio(Pipeline) Main Business
5.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
5.10.4 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Mustang Bio(Pipeline) Recent Developments
5.11 Bluebird Bio(Pipeline)
5.11.1 Bluebird Bio(Pipeline) Profile
5.11.2 Bluebird Bio(Pipeline) Main Business
5.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
5.11.4 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Bluebird Bio(Pipeline) Recent Developments
5.12 Cellectis(Pipeline)
5.12.1 Cellectis(Pipeline) Profile
5.12.2 Cellectis(Pipeline) Main Business
5.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
5.12.4 Cellectis(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Cellectis(Pipeline) Recent Developments
5.13 Allogene Therapeutics(Pipeline)
5.13.1 Allogene Therapeutics(Pipeline) Profile
5.13.2 Allogene Therapeutics(Pipeline) Main Business
5.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
5.13.4 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Allogene Therapeutics(Pipeline) Recent Developments
5.14 Celyad(Pipeline)
5.14.1 Celyad(Pipeline) Profile
5.14.2 Celyad(Pipeline) Main Business
5.14.3 Celyad(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
5.14.4 Celyad(Pipeline) CAR T-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Celyad(Pipeline) Recent Developments
6 North America
6.1 North America CAR T-Cell Therapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe CAR T-Cell Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America CAR T-Cell Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 CAR T-Cell Therapy Market Dynamics
11.1 CAR T-Cell Therapy Industry Trends
11.2 CAR T-Cell Therapy Market Drivers
11.3 CAR T-Cell Therapy Market Challenges
11.4 CAR T-Cell Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Figures
List of Tables
Table 1. Global Market CAR T-Cell Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global CAR T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global CAR T-Cell Therapy Market Size Share by Region (2018-2023)
Table 4. Global CAR T-Cell Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global CAR T-Cell Therapy Forecasted Market Size Share by Region (2024-2029)
Table 6. Global CAR T-Cell Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global CAR T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global CAR T-Cell Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global CAR T-Cell Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global CAR T-Cell Therapy Revenue Market Share by Type (2024-2029)
Table 11. North America CAR T-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America CAR T-Cell Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe CAR T-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe CAR T-Cell Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific CAR T-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific CAR T-Cell Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America CAR T-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America CAR T-Cell Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa CAR T-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa CAR T-Cell Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global CAR T-Cell Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global CAR T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global CAR T-Cell Therapy Revenue Market Share by Application (2018-2023)
Table 24. Global CAR T-Cell Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global CAR T-Cell Therapy Revenue Market Share by Application (2024-2029)
Table 26. North America CAR T-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America CAR T-Cell Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe CAR T-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe CAR T-Cell Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific CAR T-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific CAR T-Cell Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America CAR T-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America CAR T-Cell Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa CAR T-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa CAR T-Cell Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global CAR T-Cell Therapy Revenue (US$ Million) by Players (2018-2023)
Table 37. Global CAR T-Cell Therapy Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2022)
Table 39. Date of Key Players Enter into CAR T-Cell Therapy Market
Table 40. Global CAR T-Cell Therapy Key Players Headquarters and Area Served
Table 41. CAR T-Cell Therapy Product Solution and Service
Table 42. Global CAR T-Cell Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Novartis Basic Information List
Table 45. Novartis Description and Business Overview
Table 46. Novartis CAR T-Cell Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in CAR T-Cell Therapy Business of Novartis (2018-2023)
Table 48. Novartis Recent Developments
Table 49. Gilead Sciences Basic Information List
Table 50. Gilead Sciences Description and Business Overview
Table 51. Gilead Sciences CAR T-Cell Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in CAR T-Cell Therapy Business of Gilead Sciences (2018-2023)
Table 53. Gilead Sciences Recent Developments
Table 54. Bristol-Myers Squibb Basic Information List
Table 55. Bristol-Myers Squibb Description and Business Overview
Table 56. Bristol-Myers Squibb CAR T-Cell Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in CAR T-Cell Therapy Business of Bristol-Myers Squibb (2018-2023)
Table 58. Bristol-Myers Squibb Recent Developments
Table 59. J & J Basic Information List
Table 60. J & J Description and Business Overview
Table 61. J & J CAR T-Cell Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in CAR T-Cell Therapy Business of J & J (2018-2023)
Table 63. J & J Recent Developments
Table 64. JW Therapeutics Basic Information List
Table 65. JW Therapeutics Description and Business Overview
Table 66. JW Therapeutics CAR T-Cell Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in CAR T-Cell Therapy Business of JW Therapeutics (2018-2023)
Table 68. JW Therapeutics Recent Developments
Table 69. FOSUNKite Basic Information List
Table 70. FOSUNKite Description and Business Overview
Table 71. FOSUNKite CAR T-Cell Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in CAR T-Cell Therapy Business of FOSUNKite (2018-2023)
Table 73. FOSUNKite Recent Developments
Table 74. CARsgen Therapeutics (Pipeline) Basic Information List
Table 75. CARsgen Therapeutics (Pipeline) Description and Business Overview
Table 76. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in CAR T-Cell Therapy Business of CARsgen Therapeutics (Pipeline) (2018-2023)
Table 78. CARsgen Therapeutics (Pipeline) Recent Developments
Table 79. Autolus Therapeutics(Pipeline) Basic Information List
Table 80. Autolus Therapeutics(Pipeline) Description and Business Overview
Table 81. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in CAR T-Cell Therapy Business of Autolus Therapeutics(Pipeline) (2018-2023)
Table 83. Autolus Therapeutics(Pipeline) Recent Developments
Table 84. Sorrento Therapeutics(Pipeline) Basic Information List
Table 85. Sorrento Therapeutics(Pipeline) Description and Business Overview
Table 86. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in CAR T-Cell Therapy Business of Sorrento Therapeutics(Pipeline) (2018-2023)
Table 88. Sorrento Therapeutics(Pipeline) Recent Developments
Table 89. Mustang Bio(Pipeline) Basic Information List
Table 90. Mustang Bio(Pipeline) Description and Business Overview
Table 91. Mustang Bio(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in CAR T-Cell Therapy Business of Mustang Bio(Pipeline) (2018-2023)
Table 93. Mustang Bio(Pipeline) Recent Developments
Table 94. Bluebird Bio(Pipeline) Basic Information List
Table 95. Bluebird Bio(Pipeline) Description and Business Overview
Table 96. Bluebird Bio(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in CAR T-Cell Therapy Business of Bluebird Bio(Pipeline) (2018-2023)
Table 98. Bluebird Bio(Pipeline) Recent Developments
Table 99. Cellectis(Pipeline) Basic Information List
Table 100. Cellectis(Pipeline) Description and Business Overview
Table 101. Cellectis(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in CAR T-Cell Therapy Business of Cellectis(Pipeline) (2018-2023)
Table 103. Cellectis(Pipeline) Recent Developments
Table 104. Allogene Therapeutics(Pipeline) Basic Information List
Table 105. Allogene Therapeutics(Pipeline) Description and Business Overview
Table 106. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in CAR T-Cell Therapy Business of Allogene Therapeutics(Pipeline) (2018-2023)
Table 108. Allogene Therapeutics(Pipeline) Recent Developments
Table 109. Celyad(Pipeline) Basic Information List
Table 110. Celyad(Pipeline) Description and Business Overview
Table 111. Celyad(Pipeline) CAR T-Cell Therapy Products, Services and Solutions
Table 112. Revenue (US$ Million) in CAR T-Cell Therapy Business of Celyad(Pipeline) (2018-2023)
Table 113. Celyad(Pipeline) Recent Developments
Table 114. North America CAR T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 115. North America CAR T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 116. Europe CAR T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 117. Europe CAR T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 118. Asia-Pacific CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 119. Asia-Pacific CAR T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 120. Asia-Pacific CAR T-Cell Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 121. Asia-Pacific CAR T-Cell Therapy Market Share by Region (2018-2023)
Table 122. Asia-Pacific CAR T-Cell Therapy Market Share by Region (2024-2029)
Table 123. Latin America CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 124. Latin America CAR T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 125. Latin America CAR T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 126. Middle East & Africa CAR T-Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 127. Middle East & Africa CAR T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 128. Middle East & Africa CAR T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 129. CAR T-Cell Therapy Market Trends
Table 130. CAR T-Cell Therapy Market Drivers
Table 131. CAR T-Cell Therapy Market Challenges
Table 132. CAR T-Cell Therapy Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Therapy Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global CAR T-Cell Therapy Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global CAR T-Cell Therapy Market Share by Regions: 2022 VS 2029
Figure 4. Global CAR T-Cell Therapy Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America CAR T-Cell Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe CAR T-Cell Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific CAR T-Cell Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America CAR T-Cell Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa CAR T-Cell Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of CD19 - Targeted
Figure 11. Global CD19 - Targeted Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of BCMA - Targeted
Figure 13. Global BCMA - Targeted Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global CAR T-Cell Therapy Market Size Share by Type: 2022 & 2029
Figure 15. North America CAR T-Cell Therapy Revenue Market Share by Type (2018-2029)
Figure 16. Europe CAR T-Cell Therapy Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific CAR T-Cell Therapy Revenue Market Share by Type (2018-2029)
Figure 18. Latin America CAR T-Cell Therapy Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa CAR T-Cell Therapy Revenue Market Share by Type (2018-2029)
Figure 20. Lymphoma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Multiple Myeloma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Global CAR T-Cell Therapy Market Size Share by Application: 2022 & 2029
Figure 23. North America CAR T-Cell Therapy Revenue Market Share by Application (2018-2029)
Figure 24. Europe CAR T-Cell Therapy Revenue Market Share by Application (2018-2029)
Figure 25. Asia-Pacific CAR T-Cell Therapy Revenue Market Share by Application (2018-2029)
Figure 26. Latin America CAR T-Cell Therapy Revenue Market Share by Application (2018-2029)
Figure 27. Middle East and Africa CAR T-Cell Therapy Revenue Market Share by Application (2018-2029)
Figure 28. CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players CAR T-Cell Therapy Market Share in 2022
Figure 30. North America CAR T-Cell Therapy Market Share by Country (2018-2029)
Figure 31. United States CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 32. Canada CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 33. Germany CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 34. France CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 35. U.K. CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 36. Italy CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 37. Russia CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 38. Nordic Countries CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific CAR T-Cell Therapy Market Share by Region (2018-2029)
Figure 40. China CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 41. Japan CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 42. South Korea CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 43. Southeast Asia CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 44. India CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 45. Australia CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 46. Latin America CAR T-Cell Therapy Market Share by Country (2018-2029)
Figure 47. Mexico CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 48. Brazil CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa CAR T-Cell Therapy Market Share by Country (2018-2029)
Figure 50. Turkey CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 52. UAE CAR T-Cell Therapy Market Size (2018-2029) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
